Production of targeted null mutations for 10,000 genes in C57BL/6 ES cells
Ended Cooperative Agreement Awarded Last action
- Award ID
- U01HG004085
- Recipient
-
Regeneron Pharmaceuticals Inc. UEI N3F9MH7E6HD6
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $14,862,829
Award facts
- Assistance listing
- 93.172 Human Genome Research
- Completion date
- Place of performance
- Sleepy Hollow, NY 10591, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $550,000 | |
| Amendment | $728,250 | |
| Amendment | $750,000 | |
| Amendment | $1,595,238 | |
| Amendment | $471,032 | |
| Amendment | $1,000,000 | |
| Amendment | $464,389 | |
| Amendment | $1,000,000 | |
| Amendment | $728,250 | |
| Amendment | $750,000 | |
| Amendment | $475,790 | |
| Amendment | $1,185,480 | |
| Amendment | $550,000 | |
| Original award | $4,614,400 |
Show all 14
Quick answers
Who received award U01HG004085?
U01HG004085 was awarded to Regeneron Pharmaceuticals Inc. by National Institutes of Health (Department of Health and Human Services) on September 7, 2006.
How much is award U01HG004085 worth?
$14,862,829 has been obligated on U01HG004085.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award